{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:00:05Z","timestamp":1791824405730,"version":"4.3.4"},"reference-count":126,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,7,17]]},"DOI":"10.3233\/jad-161192","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T07:17:52Z","timestamp":1488784672000},"page":"421-432","source":"Crossref","is-referenced-by-count":196,"title":["The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-\u03b2, Amylin, and Tau Proteins"],"prefix":"10.1177","volume":"59","author":[{"given":"Prashant","family":"Bharadwaj","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University, WA, Australia"},{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Medical Sciences, Edith Cowan University, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeeja","family":"Wijesekara","sequence":"additional","affiliation":[{"name":"Tanz Centre for Research in Neurodegenerative Diseases, Krembil Discovery Tower, and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milindu","family":"Liyanapathirana","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Newsholme","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University, WA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ittner","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, University of NSW, Kensington, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fraser","sequence":"additional","affiliation":[{"name":"Tanz Centre for Research in Neurodegenerative Diseases, Krembil Discovery Tower, and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Verdile","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University, WA, Australia"},{"name":"Centre of Excellence for Alzheimer\u2019s Disease Research and Care, School of Medical Sciences, Edith Cowan University, WA, Australia"},{"name":"School of Psychiatry and Clinical Neurosciences, University of Western Australia, Crawley, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-161192_ref1","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2337\/db11-0499","article-title":"Amyloid-\u03b2 induces hepatic insulin resistance by activating JAK2\/STAT3\/SOCS-1 signaling pathway","volume":"61","author":"Zhang","year":"2012","journal-title":"Diabetes"},{"key":"10.3233\/JAD-161192_ref2","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00125-011-2160-2","article-title":"Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)\/PSEN1 (A246E) mouse model of Alzheimer\u2019s disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein","volume":"54","author":"Mody","year":"2011","journal-title":"Diabetologia"},{"key":"10.3233\/JAD-161192_ref3","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1096\/fj.14-268482","article-title":"Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer\u2019s disease","volume":"29","author":"Vandal","year":"2015","journal-title":"FASEB J"},{"key":"10.3233\/JAD-161192_ref4","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J"},{"key":"10.3233\/JAD-161192_ref5","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-161192_ref6","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1582-4934.2011.01384.x","article-title":"Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP\/PS1 transgenic mice","volume":"16","author":"Hiltunen","year":"2012","journal-title":"J Cell Mol Med"},{"key":"10.3233\/JAD-161192_ref7","doi-asserted-by":"crossref","first-page":"E1373","DOI":"10.1152\/ajpendo.00500.2011","article-title":"Increased A\u03b2 production prompts the onset of glucose intolerance and insulin resistance","volume":"302","author":"Jim\u00e9nez-Palomares","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.3233\/JAD-161192_ref8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.psyneuen.2015.12.001","article-title":"Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer\u2019s disease and type 2 diabetes","volume":"65","author":"Infante-Garcia","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.3233\/JAD-161192_ref9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/2051-5960-2-64","article-title":"Obesity and diabetes cause cognitive dysfunction in the absence of accelerated \u03b2-amyloid deposition in a novel murine model of mixed or vascular dementia","volume":"2","author":"Niedowicz","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-161192_ref10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-161192_ref11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: A prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-161192_ref12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","article-title":"Amyloid-\u03b2 and tau\u2013a toxic pas de deux in Alzheimer\u2019s disease","volume":"12","author":"Ittner","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-161192_ref13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.3233\/JAD-161192_ref14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00403322","article-title":"Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians","volume":"33","author":"Clark","year":"1990","journal-title":"Diabetologia"},{"key":"10.3233\/JAD-161192_ref15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/03009734000000014","article-title":"Quantitative studies on amyloid in the islets of Langerhans","volume":"77","author":"Westermark","year":"1972","journal-title":"Ups J Med Sci"},{"key":"10.3233\/JAD-161192_ref16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","article-title":"In vivo seeding and cross-seeding of localized amyloidosis: A molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"Oskarsson","year":"2015","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-161192_ref17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","article-title":"Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells","volume":"39","author":"Kahn","year":"1990","journal-title":"Diabetes"},{"key":"10.3233\/JAD-161192_ref18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000264394","article-title":"Roles of amylin in satiation, adiposity and brain development","volume":"63","author":"Lutz","year":"2010","journal-title":"Forum Nutr"},{"key":"10.3233\/JAD-161192_ref19","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00018-011-0905-1","article-title":"Control of energy homeostasis by amylin","volume":"69","author":"Lutz","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-161192_ref20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.physbeh.2011.04.044","article-title":"Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin","volume":"104","author":"Boyle","year":"2011","journal-title":"Physiol Behav"},{"key":"10.3233\/JAD-161192_ref21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.peptides.2008.02.002","article-title":"Central and peripheral administration of amylin induces energy expenditure in anesthetized rats","volume":"29","author":"Osaka","year":"2008","journal-title":"Peptides"},{"key":"10.3233\/JAD-161192_ref22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.physbeh.2010.04.012","article-title":"Central amylin acts as an adiposity signal to control body weight and energy expenditure","volume":"101","author":"Wielinga","year":"2010","journal-title":"Physiol Behav"},{"key":"10.3233\/JAD-161192_ref23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton","year":"1994","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-161192_ref24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.3233\/JAD-161192_ref25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.3233\/JAD-161192_ref26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: A second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-161192_ref27","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2174\/1567205011666141107124538","article-title":"Islet amyloid polypeptide (IAPP): A second amyloid in Alzheimer\u2019s disease","volume":"11","author":"Fawver","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-161192_ref28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: Intracellular A\u03b2 and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-161192_ref29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/JAD-131238","article-title":"Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficits","volume":"39","author":"Mehla","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-161192_ref30","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.neurobiolaging.2014.02.010","article-title":"High-fat diet-induced memory impairment in triple-transgenic Alzheimer\u2019s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology","volume":"35","author":"Knight","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-161192_ref31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3233\/JAD-140972","article-title":"Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer\u2019s disease","volume":"43","author":"Wang","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-161192_ref32","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jalz.2013.12.010","article-title":"Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer\u2019s disease","volume":"10","author":"Ferreira","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-161192_ref33","doi-asserted-by":"crossref","first-page":"105828","DOI":"10.1155\/2015\/105828","article-title":"Inflammation and oxidative stress: The molecular connectivity between insulin resistance, obesity, and Alzheimer\u2019s disease","volume":"2015","author":"Verdile","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.3233\/JAD-161192_ref34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2015.04.008","article-title":"The role of type 2 diabetes in neurodegeneration","volume":"84","author":"Verdile","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-161192_ref35","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2337\/diabetes.54.5.1264","article-title":"Insulin signaling in the central nervous system: A critical role in metabolic homeostasis and disease from C. elegans to humans","volume":"54","author":"Porte","year":"2005","journal-title":"Diabetes"},{"key":"10.3233\/JAD-161192_ref36","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.2337\/dbi15-0011","article-title":"A key role of insulin receptors in memory","volume":"64","author":"De Felice","year":"2015","journal-title":"Diabetes"},{"key":"10.3233\/JAD-161192_ref37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease","volume":"105","author":"Fr\u00f6lich","year":"1998","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-161192_ref38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019s disease: Link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-161192_ref39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-161192_ref40","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-161192_ref41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-161192_ref42","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: Suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-161192_ref43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer\u2019s disease: Relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JAD-161192_ref44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-161192_ref45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/10408360903335821","article-title":"The structure and function of Alzheimer\u2019s gamma secretase enzyme complex","volume":"46","author":"Krishnaswamy","year":"2009","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.3233\/JAD-161192_ref46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-12-385883-2.00012-6","article-title":"Alzheimer\u2019s disease and the amyloid \u03b2-protein","volume":"107","author":"Walsh","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.3233\/JAD-161192_ref47","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.4161\/auto.21861","article-title":"Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions","volume":"8","author":"Son","year":"2012","journal-title":"Autophagy"},{"key":"10.3233\/JAD-161192_ref48","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.2337\/db14-0375","article-title":"Insulin reverses the high-fat diet-induced increase in brain A\u03b2 and improves memory in an animal model of Alzheimer disease","volume":"63","author":"Vandal","year":"2014","journal-title":"Diabetes"},{"key":"10.3233\/JAD-161192_ref49","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-161192_ref50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-2002-4504","article-title":"Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor","volume":"4","author":"Ling","year":"2002","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-161192_ref51","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer\u2019s-linked toxins: Insulin signaling prevents the pathogenic binding of Abeta oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-161192_ref52","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-161192_ref53","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J"},{"key":"10.3233\/JAD-161192_ref54","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/BST20120080","article-title":"Insulin and IGF-1 signalling: Longevity, protein homoeostasis and Alzheimer\u2019s disease","volume":"40","author":"O\u2019Neill","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-161192_ref55","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","article-title":"GSK-3: Tricks of the trade for a multi-tasking kinase","volume":"116","author":"Doble","year":"2003","journal-title":"J Cell Sci"},{"key":"10.3233\/JAD-161192_ref56","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1523\/JNEUROSCI.23-18-07084.2003","article-title":"Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation","volume":"23","author":"Schubert","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-161192_ref57","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-161192_ref58","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.3233\/JAD-161192_ref59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer\u2019s disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.3233\/JAD-161192_ref60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1326-9-30","article-title":"Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin","volume":"9","author":"Srodulski","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-161192_ref61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1110\/ps.48702","article-title":"Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: Implications for the study of amyloid formation","volume":"11","author":"Nilsson","year":"2002","journal-title":"Protein Sci"},{"key":"10.3233\/JAD-161192_ref62","doi-asserted-by":"crossref","first-page":"2798269","DOI":"10.1155\/2016\/2798269","article-title":"Islet amyloid polypeptide: Structure, function, and pathophysiology","volume":"2016","author":"Akter","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.3233\/JAD-161192_ref63","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1073\/pnas.0509386103","article-title":"Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer\u2019s disease","volume":"103","author":"Guo","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-161192_ref64","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","article-title":"beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"98","author":"Masliah","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-161192_ref65","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.febslet.2008.05.006","article-title":"Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures","volume":"582","author":"Lim","year":"2008","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-161192_ref66","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbadis.2014.01.002","article-title":"Exogenous amyloidogenic proteins function as seeds in amyloid \u03b2-protein aggregation","volume":"1842","author":"Ono","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-161192_ref67","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/anie.200604056","article-title":"IAPP mimic blocks Abeta cytotoxic self-assembly: Cross-suppression of amyloid toxicity of Abeta and IAPP suggests a molecular link between Alzheimer\u2019s disease and type II diabetes","volume":"46","author":"Yan","year":"2007","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.3233\/JAD-161192_ref68","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/anie.200904902","article-title":"Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association","volume":"49","author":"Andreetto","year":"2010","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.3233\/JAD-161192_ref69","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2174\/13816128113199990064","article-title":"Molecular characterization of the hetero-assembly of \u03b2-amyloid peptide with islet amyloid polypeptide","volume":"20","author":"Yan","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-161192_ref70","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer\u2019s disease brain: Central role for amyloid beta-peptide","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.3233\/JAD-161192_ref71","doi-asserted-by":"crossref","first-page":"18210","DOI":"10.1016\/S0021-9258(19)37174-1","article-title":"Amyloidogenicity of \u03b2A4 and \u03b2A4-bearing amyloid protein precursor fragments by metal-catalysed oxidation","volume":"267","author":"Dyrks","year":"1992","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-161192_ref72","doi-asserted-by":"crossref","first-page":"19506","DOI":"10.1074\/jbc.M112218200","article-title":"Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers","volume":"277","author":"Palmblad","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-161192_ref73","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links Abeta to mitochondrial toxicity in Alzheimer\u2019s disease","volume":"304","author":"Lustbader","year":"2004","journal-title":"Science"},{"key":"10.3233\/JAD-161192_ref74","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1471-4159.1986.tb00615.x","article-title":"Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer\u2019s disease may reflect oxidative stress","volume":"46","author":"Martins","year":"1986","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-161192_ref75","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1172\/JCI119772","article-title":"Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer\u2019s disease","volume":"100","author":"Yaar","year":"1997","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-161192_ref76","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/brain\/awf205","article-title":"Abeta 17-42 in Alzheimer\u2019s disease activates JNK and caspase-8 leading to neuronal apoptosis","volume":"125","author":"Wei","year":"2002","journal-title":"Brain"},{"key":"10.3233\/JAD-161192_ref77","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/JMN:23:1-2:097","article-title":"Cell degeneration induced by amyloid-beta peptides: Implications for Alzheimer\u2019s disease","volume":"23","author":"Pereira","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-161192_ref78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1326-4-14","article-title":"The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events","volume":"4","author":"Bhaskar","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-161192_ref79","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresrev.2004.07.018","article-title":"Signal transduction during amyloid-beta-peptide neurotoxicity: Role in Alzheimer disease","volume":"47","author":"Fuentealba","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"key":"10.3233\/JAD-161192_ref80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-8993(93)90295-X","article-title":"Calcium-destablizing and neurodegenerative effect of aggregated beta-amyloid peptide are attenuated by basic FGF","volume":"621","author":"Mattson","year":"1993","journal-title":"Brain Res"},{"key":"10.3233\/JAD-161192_ref81","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/0024-3205(94)00381-5","article-title":"Disturbances of the neuronal calcium homeostasis in the aging nervous system","volume":"55","author":"Hartmann","year":"1994","journal-title":"Life Sci"},{"key":"10.3233\/JAD-161192_ref82","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/bst0290617","article-title":"Membrane-disordering effects of beta-amyloid peptides","volume":"29","author":"M\u00fcller","year":"2001","journal-title":"Biochem Soc Trans"},{"key":"10.3233\/JAD-161192_ref83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/psc.573","article-title":"Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: Binding sites and implications for Alzheimer\u2019s disease","volume":"10","author":"Verdier","year":"2004","journal-title":"J Pept Sci"},{"key":"10.3233\/JAD-161192_ref84","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1523\/JNEUROSCI.16-19-06021.1996","article-title":"Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia","volume":"16","author":"Giulian","year":"1996","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-161192_ref85","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.3233\/JAD-161192_ref86","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/15216540701283882","article-title":"Soluble protein oligomers as emerging toxins in Alzheimer\u2019s and other amyloid diseases","volume":"59","author":"Ferreira","year":"2007","journal-title":"IUBMB Life"},{"key":"10.3233\/JAD-161192_ref87","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1212\/01.wnl.0000192103.24796.42","article-title":"Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis","volume":"66","author":"Glabe","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-161192_ref88","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1582-4934.2009.00609.x","article-title":"Abeta aggregation and possible implications in Alzheimer\u2019s disease pathogenesis","volume":"13","author":"Bharadwaj","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.3233\/JAD-161192_ref89","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1471-4159.1993.tb07480.x","article-title":"Neurotoxicity of human amylin in rat primary hippocampal cultures: Similarity to Alzheimer\u2019s disease amyloid-beta neurotoxicity","volume":"61","author":"May","year":"1993","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-161192_ref90","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/pmic.200900651","article-title":"Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction","volume":"10","author":"Lim","year":"2010","journal-title":"Proteomics"},{"key":"10.3233\/JAD-161192_ref91","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1074\/jbc.R115.702704","article-title":"Amyloid-\u03b2 receptors: The good, the bad, and the prion protein","volume":"291","author":"Jarosz-Griffiths","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-161192_ref92","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-161192_ref93","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.neurobiolaging.2008.08.019","article-title":"Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes","volume":"31","author":"Miklossy","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-161192_ref94","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000216274.58185.09","article-title":"Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease","volume":"66","author":"Kulstad","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-161192_ref95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000338704","article-title":"Oral glucose loading modulates plasma \u03b2-amyloid level in Alzheimer\u2019s disease patients: Potential diagnostic method for Alzheimer\u2019s disease","volume":"34","author":"Takeda","year":"2012","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-161192_ref96","doi-asserted-by":"crossref","first-page":"e69824","DOI":"10.1371\/journal.pone.0069824","article-title":"High glucose promotes A\u03b2 production by inhibiting APP degradation","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-161192_ref97","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","article-title":"Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling","volume":"21","author":"Gasparini","year":"2001","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-161192_ref98","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2337\/db12-0670","article-title":"Amyloid-\u03b2 induces hepatic insulin resistance in vivo via JAK2","volume":"62","author":"Zhang","year":"2013","journal-title":"Diabetes"},{"key":"10.3233\/JAD-161192_ref99","first-page":"53","article-title":"The role of insulin resistance and glucose metabolism dysregulation in the development of Alzheimer\u2019s disease","volume":"68","author":"Arrieta-Cruz","year":"2016","journal-title":"Rev Invest Clin"},{"key":"10.3233\/JAD-161192_ref100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.15252\/emmm.201404183","article-title":"Alzheimer-associated A\u03b2 oligomers impact the central nervous system to induce peripheral metabolic deregulation","volume":"7","author":"Clarke","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-161192_ref101","first-page":"681","article-title":"Molecular features of hypothalamic plaques in Alzheimer\u2019s disease","volume":"139","author":"Standaert","year":"1991","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-161192_ref102","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20110512","article-title":"Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice","volume":"441","author":"Meakin","year":"2012","journal-title":"Biochem J"},{"key":"10.3233\/JAD-161192_ref103","doi-asserted-by":"crossref","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","article-title":"Alzheimer\u2019s beta-amyloid peptides compete for insulin binding to the insulin receptor","volume":"22","author":"Xie","year":"2002","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-161192_ref104","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2001-3405","article-title":"Abetapp secretases are co-expressed with Abetapp in the pancreatic islets","volume":"3","author":"Figueroa","year":"2001","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-161192_ref105","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/acschemneuro.5b00192","article-title":"Cross-seeding interaction between \u03b2-amyloid and human islet amyloid polypeptide","volume":"6","author":"Hu","year":"2015","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-161192_ref106","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1471-4159.1996.67031235.x","article-title":"Tau is widely expressed in rat tissues","volume":"67","author":"Gu","year":"1996","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-161192_ref107","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1677\/JOE-09-0341","article-title":"Expression of TAU in insulin-secreting cells and its interaction with the calcium-binding protein secretagogin","volume":"205","author":"Maj","year":"2010","journal-title":"J Endocrinol"},{"key":"10.3233\/JAD-161192_ref108","first-page":"1964634","article-title":"The microtubule-associated protein tau and its relevance for pancreatic beta cells","volume":"2006","author":"Maj","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.3233\/JAD-161192_ref109","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1210\/endo.131.1.1612013","article-title":"The identification, purification, and characterization of a pancreatic beta-cell form of the microtubule adenosine triphosphatase kinesin","volume":"131","author":"Balczon","year":"1992","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-161192_ref110","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1210\/endo.138.5.5139","article-title":"Suppression of the expression of a pancreatic beta-cell form of the kinesin heavy chain by antisense oligonucleotides inhibits insulin secretion from primary cultures of mouse beta-cells","volume":"138","author":"Meng","year":"1997","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-161192_ref111","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1083\/jcb.93.1.164","article-title":"Association between endocrine pancreatic secretory granules and in-vitro-assembled microtubules is dependent upon microtubule-associated proteins","volume":"93","author":"Suprenant","year":"1982","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-161192_ref112","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2362.1974.tb00409.x","article-title":"Dynamics of insulin release and microtubular-microfilamentous system. V. A model for the phasic release of insulin","volume":"4","author":"Malaisse","year":"1974","journal-title":"Eur J Clin Invest"},{"key":"10.3233\/JAD-161192_ref113","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.devcel.2015.08.020","article-title":"Microtubules negatively regulate insulin secretion in pancreatic \u03b2 cells","volume":"34","author":"Zhu","year":"2015","journal-title":"Dev Cell"},{"key":"10.3233\/JAD-161192_ref114","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1590\/0001-3765201520140225","article-title":"General aspects of muscle glucose uptake","volume":"87","author":"Alvim","year":"2015","journal-title":"An Acad Bras Cienc"},{"key":"10.3233\/JAD-161192_ref115","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1074\/jbc.M007610200","article-title":"Insulin-mediated GLUT4 translocation is dependent on the microtubule network","volume":"276","author":"Olson","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-161192_ref116","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/bj3520267","article-title":"Role for the microtubule cytoskeleton in GLUT4 vesicle trafficking and in the regulation of insulin-stimulated glucose uptake","volume":"352","author":"Fletcher","year":"2000","journal-title":"Biochem J"},{"key":"10.3233\/JAD-161192_ref117","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mce.2012.09.005","article-title":"Microtubule network is required for insulin-induced signal transduction and actin remodeling","volume":"365","author":"Liu","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.3233\/JAD-161192_ref118","doi-asserted-by":"crossref","first-page":"19547","DOI":"10.1074\/jbc.272.31.19547","article-title":"Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons","volume":"272","author":"Hong","year":"1997","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-161192_ref119","doi-asserted-by":"crossref","first-page":"10677","DOI":"10.1074\/jbc.M010785200","article-title":"A role for kinesin in insulin-stimulated GLUT4 glucose transporter translocation in 3T3-L1 adipocytes","volume":"276","author":"Emoto","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-161192_ref120","doi-asserted-by":"crossref","first-page":"17401","DOI":"10.1523\/JNEUROSCI.3028-12.2012","article-title":"Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor","volume":"32","author":"Kimura","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-161192_ref121","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1139\/y95-146","article-title":"Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain","volume":"73","author":"Christopoulos","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"10.3233\/JAD-161192_ref122","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnagi.2013.00038","article-title":"Lessons from two prevalent amyloidoses\u2014 what amylin and A\u03b2 have in common","volume":"5","author":"G\u00f6tz","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-161192_ref123","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/1753-0407.12034","article-title":"Novel therapies for the management of type 2 diabetes mellitus: Part 1. pramlintide and bromocriptine-QR","volume":"5","author":"Grunberger","year":"2013","journal-title":"J Diabetes"},{"key":"10.3233\/JAD-161192_ref124","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2014.17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease","volume":"20","author":"Zhu","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-161192_ref125","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer\u2019s disease pathogenesis and cognition","volume":"35","author":"Adler","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-161192_ref126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/alzrt162","article-title":"Plasma amyloid beta measurements - a desired but elusive Alzheimer\u2019s disease biomarker","volume":"5","author":"Toledo","year":"2013","journal-title":"Alzheimers Res Ther"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-161192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:06Z","timestamp":1777370646000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-161192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":126,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-161192","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,17]]}}}